• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients.主动脉瓣狭窄患者主动脉瓣置换术后的死亡预测因素
Pathophysiology. 2022 Mar 9;29(1):106-117. doi: 10.3390/pathophysiology29010010.
2
Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.心脏不停跳下的主动脉瓣和二尖瓣手术正在缩短体外循环和主动脉阻断时间。
Heart Surg Forum. 2002;5(2):182-6.
3
4
Echocardiographic predictors of adverse short-term outcomes after heart surgery in patients with mitral regurgitation and pulmonary hypertension.二尖瓣反流和肺动脉高压患者心脏手术后不良短期预后的超声心动图预测指标
Heart Surg Forum. 2012 Jun;15(3):E127-32. doi: 10.1532/HSF98.20121008.
5
Transaortic repair of concomitant mitral insufficiency in patients with critical aortic stenosis undergoing aortic valvular replacement.在接受主动脉瓣膜置换术的严重主动脉瓣狭窄患者中经主动脉修复合并存在的二尖瓣关闭不全。
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Jan 1;27(1):9-14. doi: 10.5606/tgkdc.dergisi.2019.16105. eCollection 2019 Jan.
6
Analysis of risk factors for valve replacements in 5,128 cases from a single heart center in China.中国单一心脏中心 5128 例瓣膜置换术的风险因素分析。
Chin Med J (Engl). 2010 Dec;123(24):3509-14.
7
Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.孤立性严重主动脉瓣狭窄伴左心室功能障碍患者的主动脉瓣置换术:长期生存率和心室恢复情况。
Anadolu Kardiyol Derg. 2009 Feb;9(1):41-6.
8
Echocardiographic predictors of left ventricular functional recovery following valve replacement surgery for severe aortic stenosis.严重主动脉瓣狭窄瓣膜置换术后左心室功能恢复的超声心动图预测指标
Int J Cardiol. 2008 Aug 18;128(2):178-84. doi: 10.1016/j.ijcard.2007.05.025. Epub 2007 Aug 15.
9
Tricuspid Regurgitation Is Associated With Increased Risk of Mortality in Patients With Low-Flow Low-Gradient Aortic Stenosis and Reduced Ejection Fraction: Results of the Multicenter TOPAS Study (True or Pseudo-Severe Aortic Stenosis).三尖瓣反流与射血分数降低的低流量低梯度主动脉瓣狭窄患者死亡率增加相关:多中心 TOPAS 研究(真性或假性重度主动脉瓣狭窄)的结果。
JACC Cardiovasc Interv. 2015 Apr 20;8(4):588-96. doi: 10.1016/j.jcin.2014.08.019. Epub 2015 Mar 26.
10
Comparing the endo-aortic balloon and the external aortic clamp in minimally invasive mitral valve surgery.在微创二尖瓣手术中比较主动脉内球囊和主动脉外夹闭器。
Interact Cardiovasc Thorac Surg. 2015 Sep;21(3):359-65. doi: 10.1093/icvts/ivv160. Epub 2015 Jun 20.

引用本文的文献

1
Impact of a New Preoperative Stratification Based on Cardiac Structural Compromise in Patients with Severe Aortic Stenosis Undergoing Valve Replacement Surgery.基于心脏结构受损的新术前分层对重度主动脉瓣狭窄患者行瓣膜置换手术的影响。
Diagnostics (Basel). 2024 Oct 9;14(19):2250. doi: 10.3390/diagnostics14192250.
2
Early extubation after elective surgical aortic valve replacement during the COVID-19 pandemic.择期手术主动脉瓣置换术后 COVID-19 大流行期间的早期拔管。
J Cardiothorac Surg. 2024 Aug 24;19(1):490. doi: 10.1186/s13019-024-02989-0.
3
The Role of «Novel» Biomarkers of Systemic Inflammation in the Development of Early Hospital Events after Aortic Valve Replacement in Patients with Aortic Stenosis.全身炎症“新型”生物标志物在主动脉瓣狭窄患者主动脉瓣置换术后早期医院事件发生中的作用
Life (Basel). 2023 Jun 14;13(6):1395. doi: 10.3390/life13061395.

本文引用的文献

1
Aortic Valve Replacement Versus Conservative Treatment in Asymptomatic Severe Aortic Stenosis: The AVATAR Trial.主动脉瓣置换与保守治疗无症状重度主动脉瓣狭窄:AVATAR 试验。
Circulation. 2022 Mar;145(9):648-658. doi: 10.1161/CIRCULATIONAHA.121.057639. Epub 2021 Nov 13.
2
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会心脏瓣膜病管理指南。
Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389.
3
Guideline Update on Indications for Transcatheter Aortic Valve Implantation Based on the 2020 American College of Cardiology/American Heart Association Guidelines for Management of Valvular Heart Disease.基于2020年美国心脏病学会/美国心脏协会瓣膜性心脏病管理指南的经导管主动脉瓣植入术适应证指南更新
JAMA Cardiol. 2021 Sep 1;6(9):1088-1089. doi: 10.1001/jamacardio.2021.2534.
4
Therapeutic Controversies in the Medical Management of Valvular Heart Disease.瓣膜性心脏病的医学治疗争议
Ann Pharmacother. 2021 Nov;55(11):1379-1385. doi: 10.1177/1060028021992329. Epub 2021 Feb 6.
5
The year in cardiovascular medicine 2020: valvular heart disease.2020年心血管医学领域:心脏瓣膜病
Eur Heart J. 2021 Feb 11;42(6):647-656. doi: 10.1093/eurheartj/ehaa1060.
6
Determinants of acute kidney injury after cardiac surgery: a systematic review.心脏手术后急性肾损伤的决定因素:系统评价。
Rev Cardiovasc Med. 2020 Dec 30;21(4):601-610. doi: 10.31083/j.rcm.2020.04.206.
7
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020美国心脏病学会/美国心脏协会瓣膜性心脏病患者管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2021 Feb 2;143(5):e72-e227. doi: 10.1161/CIR.0000000000000923. Epub 2020 Dec 17.
8
The Association Between Obesity and Risk of Acute Kidney Injury After Cardiac Surgery.肥胖与心脏手术后急性肾损伤风险的关联。
Front Endocrinol (Lausanne). 2020 Oct 6;11:534294. doi: 10.3389/fendo.2020.534294. eCollection 2020.
9
Evaluation and Management of Premature Ventricular Complexes.室性期前收缩的评估与处理。
Circulation. 2020 Apr 28;141(17):1404-1418. doi: 10.1161/CIRCULATIONAHA.119.042434. Epub 2020 Apr 27.
10
Exploring Current Evidence on the Past, the Present, and the Future of the Heart Team: A Narrative Review.探索心脏团队过去、现在和未来的现有证据:叙事性综述。
Cardiovasc Ther. 2020 Jan 4;2020:9241081. doi: 10.1155/2020/9241081. eCollection 2020.

主动脉瓣狭窄患者主动脉瓣置换术后的死亡预测因素

Predictors of Mortality Following Aortic Valve Replacement in Aortic Stenosis Patients.

作者信息

Shvartz Vladimir, Sokolskaya Maria, Petrosyan Andrey, Ispiryan Artak, Donakanyan Sergey, Bockeria Leo, Bockeria Olga

机构信息

Department of Surgical Treatment for Interactive Pathology, Bakoulev Scientific Center for Cardiovascular Surgery, Rublevskoe Shosse, 135, 121552 Moscow, Russia.

出版信息

Pathophysiology. 2022 Mar 9;29(1):106-117. doi: 10.3390/pathophysiology29010010.

DOI:10.3390/pathophysiology29010010
PMID:35366293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8955830/
Abstract

Background: Understanding of the risk factors for the development of adverse outcomes after aortic valve replacement is necessary to develop timely preventive measures and to improve the results of surgical treatment. Methods: We analyzed patients with aortic stenosis (n = 742) who underwent surgical treatment in the period 2014−2020. The average age was 63 (57;69) years—men 58%, women 42%. Results: The hospital mortality rate was 3% (22 patients). The following statistically significant threshold values (cut-off points) were obtained in the ROC analysis: aortic cross-clamp time > 93 min AUC (CI) 0.676 (0.640−0.710), p = 0.010; cardiopulmonary bypass time > 144 min AUC (CI) 0.809 (0.778−0.837), p < 0.0001, hemoglobin before op <120 g/L. AUC (CI) 0.762 (0.728−0.793), p < 0.0001, hematocrit before op <39% AUC (CI) 0.755 (0.721−0.786), p < 0.001, end-diastolic dimension index >2.39 AUC (CI) 0.647 (0.607−0.686), p = 0.014, end-systolic dimension index > 1.68 AUC (CI) 0.657 (0.617−0.695), p = 0.009. Statistically significant independent predictors of hospital mortality were identified: BMI > 30 kg/m2 (OR 2.84; CI 1.15−7.01), ischemic heart disease (OR 3.65; CI 1.01−13.2), diabetes (OR 3.88; CI 1.38−10.9), frequent ventricular ectopy before operation (OR 9.78; CI 1.91−50.2), mitral valve repair (OR 4.47; CI 1.76−11.3), tricuspid valve repair (OR 3.06; CI 1.09−8.58), 3 and more procedures (OR 4.44; CI 1.67−11.8). Conclusions: The hospital mortality rate was 3%. The main indicators associated with the risk of death were: diabetes, overweight (body mass index more than 30 kg/m2), frequent ventricular ectopy before surgery, hemoglobin level below 120 g/L, hematocrit level below 39%, longer cardiopulmonary bypass time and aortic cross-clamp time, additional mitral and tricuspid valve interventions.

摘要

背景

了解主动脉瓣置换术后不良结局发生的风险因素对于制定及时的预防措施和改善手术治疗效果至关重要。方法:我们分析了2014 - 2020年期间接受手术治疗的主动脉瓣狭窄患者(n = 742)。平均年龄为63(57;69)岁,男性占58%,女性占42%。结果:医院死亡率为3%(22例患者)。在ROC分析中获得了以下具有统计学意义的阈值(截断点):主动脉阻断时间> 93分钟,AUC(CI)0.676(0.640 - 0.710),p = 0.010;体外循环时间> 144分钟,AUC(CI)0.809(0.778 - 0.837),p < 0.0001,术前血红蛋白<120 g/L,AUC(CI)0.762(0.728 - 0.793),p < 0.0001,术前血细胞比容<39%,AUC(CI)0.755(0.721 - 0.786),p < 0.001,舒张末期内径指数>2.39,AUC(CI)0.647(0.607 - 0.686),p = 0.014,收缩末期内径指数> 1.68,AUC(CI)0.657(0.617 - 0.695),p = 0.009。确定了具有统计学意义的医院死亡率独立预测因素:BMI> 30 kg/m²(OR 2.84;CI 1.15 - 7.01),缺血性心脏病(OR 3.65;CI 1.01 - 13.2),糖尿病(OR 3.88;CI 1.38 - 10.9),术前频发室性早搏(OR 9.78;CI 1.91 - 50.2),二尖瓣修复(OR 4.47;CI 1.76 - 11.3),三尖瓣修复(OR 3.06;CI 1.09 - 8.58),3项及以上手术(OR 4.44;CI 1.67 - 11.8)。结论:医院死亡率为3%。与死亡风险相关的主要指标为:糖尿病、超重(体重指数超过30 kg/m²)、术前频发室性早搏、血红蛋白水平低于120 g/L、血细胞比容水平低于39%、体外循环时间和主动脉阻断时间较长、二尖瓣和三尖瓣额外干预。